Positron emission tomography (PET) studies of dopaminergic/cholinergic interactions in the baboon brain.
Interactions between the dopaminergic D2 receptor system and the muscarinic cholinergic system in the corpus striatum of adult female baboons (Papio anubis) were examined using positron emission tomography (PET) combined with [18F]N-methylspiroperidol [( 18F]NMSP) (to probe D2 receptor availability) and [N-11C-methyl]benztropine (to probe muscarinic cholinergic receptor availability). Pretreatment with benztropine, a long-lasting anticholinergic drug, bilaterally reduced the incorporation of radioactivity in the corpus striatum but did not alter that observed in the cerebellum or the rate of metabolism of [18F]NMSP in plasma. Pretreatment with unlabelled NMSP, a potent dopaminergic antagonist, reduced the incorporation of [N-11C-methyl]benztropine in all brain regions, with the greatest effect being in the corpus striatum greater than cortex greater than thalamus greater than cerebellum, but did not alter the rate of metabolism of the labelled benztropine in the plasma. These reductions in the incorporation of either [18F]NMSP or [N-11C-methyl]benztropine exceeded the normal variation in tracer incorporation in repeated studies in the same animal. This study demonstrates that PET can be used as a tool for investigating interactions between neurochemically different yet functionally linked neurotransmitters systems in vivo and provides insight into the consequences of multiple pharmacologic administration.
Dewey
S L
SL
Brookhaven National Laboratory, Upton, New York 11973.
Brodie
J D
JD
Fowler
J S
JS
MacGregor
R R
RR
Schlyer
D J
DJ
King
P T
PT
Alexoff
D L
DL
Volkow
N D
ND
Shiue
C Y
CY
Wolf
A P
AP
D000818:Animals; D001921:Brain / Q000000981:diagnostic imaging / Q000502:physiology*; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism; D004298:Dopamine / Q000502:physiology*; D015259:Dopamine Agents / Q000494:pharmacology*; D005260:Female; D005462:Fluorine Radioisotopes; D010215:Papio; D010275:Parasympathetic Nervous System / Q000502:physiology*; D013134:Spiperone / Q000031:analogs & derivatives* / Q000494:pharmacology; D014055:Tomography, Emission-Computed
D015259:Dopamine Agents; D005462:Fluorine Radioisotopes; D013134:Spiperone; C039167:3-N-methylspiperone; D004298:Dopamine